Skip to content
DefDex

Federal award

SAREPTA THERAPEUTICS, INC.

HDTRA107C0010

Contract

Obligated and Ceiling

Obligated (net)
$20,456,617.44
Ceiling (potential value, not spending)
$45,359,554.17
Current value
$45,359,554.17
Gross positive obligations
$27,397,533.17

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
SAREPTA THERAPEUTICS, INC. · YKM9HZ3EH6X1
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
SAREPTA THERAPEUTICS, INC. · FVMHHCGQKM83
Awarding agency
Department of War · sub-agency 9761 · office HDTRA1
Funding agency
Department of War · sub-agency 9761
Product or service (PSC)
AA13 · AGRICULTURE R&D SERVICES; AGRICULTURAL RESEARCH AND SERVICES; EXPERIMENTAL DEVELOPMENT
Industry (NAICS)
541710 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES
PIID
HDTRA107C0010
Award type code
D
Actions
15 · Feb 20, 2008 to Sep 14, 2015
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History15

Award actions
DateFYModAction typeObligationCompany in company totals
Sep 14, 2015FY2015P00016M−$1,021,207.75
—
May 9, 2014FY2014P00015M−$0.01
—
Feb 24, 2011FY2011P00014B$0.00
—
Dec 1, 2010FY2011P00013C−$3,000,000.00
—
Jun 29, 2010FY2010P00012C−$2,919,707.97
—
Apr 20, 2010FY2010P00011B$0.00
—
Mar 23, 2010FY2010P00010C$5,919,707.97
—
Nov 30, 2009FY2010P00009M$0.00
—
Sep 30, 2009FY2009P00008B$5,601,194.00
—
Sep 10, 2009FY2009P00007D$2,850,511.57
—
Jul 1, 2009FY2009P00006M$0.00
—
May 28, 2009FY2009P00005D$2,954,122.63
—
Nov 14, 2008FY2009P00004B$0.00
—
Mar 25, 2008FY2008P00003C$3,571,997.00
—
Feb 20, 2008FY2008P00002C$6,500,000.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.